NSPR - InspireMD Inc logo

InspireMD Inc

NSPR

InspireMD Inc develops and markets medical devices for carotid artery disease and vascular conditions. Its key products include the MicroNet stent platform, CGuard carotid embolic prevention system, CGuard Prime stent, and SwitchGuard neuroprotection system.

โš•๏ธ Healthcare NASDAQ Listed 2011 $ USD
$1,000 invested 10 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth23.48%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth20.82%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.8
Net Growth-150.24%
Net Trend20%
Net Income Consistencyโ€”
Rev Growth141.33%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth-341.21%
Net Trend30%
Net Income Consistency
Rev Growth472.76%
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth-112.14%
Net Trend43%
Net Income Consistency
Rev Growth102.80%
Rev Trend56%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where InspireMD Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. NSPR does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-01
$ 0.62โ€”
1 Year2025-10-01
$ 2.40-74.18%
5 Years2021-10-01
$ 4.14-85.03%
10 Years2016-09-30
$ 52.5K-100.00%
All Time2011-04-12
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 10M-$ 37M$ 41M
2025$ 8M-$ 48M$ 54M
2024$ 7M-$ 32M$ 34M
2023$ 6M-$ 19M$ 39M
2022$ 5M-$ 18M$ 17M
2021$ 4M-$ 14M$ 34M
2020$ 2M-$ 10M$ 12M
2019$ 3M-$ 10M$ 5M
2018$ 3M-$ 7M$ 9M
2017$ 2M-$ 8M$ 3M
2016$ 1M-$ 8M$ 7M
2015$ 2M-$ 15M$ 3M
2014$ 2M-$ 25M$ 6M
2013$ 4M-$ 29M$ 17M
2012$ 5M-$ 17M$ 10M
2012$ 5M
IPO2011$ 5M-$ 17M$ 10M
NSPR - InspireMD Inc logo

InspireMD Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 2M to $ 8M and net income went from -$ 10M to -$ 48M. Revenue increased in every one of those 5 years; net income in 1.

Between 2015 and 2025, revenue grew from $ 2M to $ 8M and net income went from -$ 15M to -$ 48M. Revenue increased in 9 of those 10 years; net income in 3.

InspireMD Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.

Membership

Explore NSPR with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,813 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies